Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS

Hospitals worldwide are experiencing a shortage in essential intravenous sedative medications. This is attributable to high number and high sedative needs of COVID-19 critical care patients with disruption of drug supply chains. Inhaled volatile anesthetic agents are an abundant resource and readily...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerath, Angela, Ferguson, Niall D., Cuthbertson, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315695/
https://www.ncbi.nlm.nih.gov/pubmed/32588067
http://dx.doi.org/10.1007/s00134-020-06154-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315695/
https://www.ncbi.nlm.nih.gov/pubmed/32588067
http://dx.doi.org/10.1007/s00134-020-06154-8

Ejemplares similares